Fish Oil Supplements Did Not Prevent Memory Loss or Brain Shrinkage in Two-Year Study
Millions of Americans take fish oil supplements to protect their memory and support brain health as they age. Americans spend more than $1 billion each year on supplements containing omega-3 fatty acids, essential nutrients that help build and maintain connections between brain cells involved in memory, learning, and other cognitive functions.
However, new research suggests that taking high-dose omega-3 supplements may not provide the protection against cognitive decline that many people expect.
Researchers at the University of Southern California’s Keck Medicine found that even when omega-3 fatty acids reached the brain, they produced no measurable improvements in memory or thinking ability and did not prevent brain atrophy.
The findings, published in EBioMedicine, came from a two-year clinical trial involving older adults at high risk of developing Alzheimer’s disease. Participants who took daily omega-3 supplements experienced no significant cognitive benefit compared with those who took a placebo.
“While we all wish there was a magic bullet to prevent Alzheimer’s disease, our findings show that fish oil supplements do not appear to be effective in protecting brain health,” said Hussein Naji Yassin, M.D., director of the USC Center for Personalized Brain Health and principal investigator of the study. “Omega-3s play an important role in forming brain cell connections necessary for cognition, but our findings do not support fish oil supplements as a preventive measure against Alzheimer’s disease.”
Two-year study examined fish oil and brain health
To investigate whether omega-3 supplements could protect the aging brain, researchers enrolled 365 adults between the ages of 55 and 80. All participants ate little fish, a major dietary source of omega-3 fatty acids, and were considered to be at high risk for Alzheimer’s disease.
Almost half of the participants, 47%, had APOE4, a genetic variant associated with a significantly higher risk of developing Alzheimer’s disease later in life. Having APOE4 does not guarantee that a person will develop the disease, but it is the strongest known genetic risk factor for late-onset Alzheimer’s disease.
Participants were randomly assigned to take either a daily fish oil supplement or a placebo, an inactive treatment used for comparison. The supplement contained 2,000 milligrams of docosahexaenoic acid, or DHA, an omega-3 fatty acid that is especially important for the brain.
DHA is a major component of brain cell membranes. It helps maintain neuron structure and function, supports communication between nerve cells, and contributes to normal brain activity.
The study was conducted using a double-blind design, meaning that neither the participants nor the researchers knew who was taking the active supplement during the trial. This approach helps reduce bias and makes it easier to determine whether observed effects were caused by the treatment.
Omega-3 levels increased, but memory did not improve
Before determining whether the supplements improved brain health, researchers first needed to establish whether the omega-3 fatty acids reached the brain.
They measured DHA concentrations in cerebrospinal fluid, the clear fluid that surrounds and cushions the brain and spinal cord. Testing this fluid provides information about substances that enter and circulate within the central nervous system.
After six months, DHA levels in the cerebrospinal fluid of participants taking the supplement had increased by an average of 17%. This indicated that omega-3 fatty acids were reaching the central nervous system.
However, getting DHA into the brain was only part of the goal. The more important question was whether the higher levels improved brain health.
Researchers assessed participants’ memory and other cognitive abilities at the beginning of the trial and again two years later. Despite the increase in DHA, participants who took fish oil did not perform better on cognitive tests than those who took the placebo.
Brain imaging produced similarly disappointing results. Fish oil supplements did not prevent the hippocampus from shrinking. The hippocampus is a deep brain region that plays a central role in forming and organizing memories. It is also particularly vulnerable to changes associated with aging and Alzheimer’s disease, making its size an important indicator in brain-health research.
Together, the findings suggest that simply increasing DHA availability in the brain is not enough to produce measurable cognitive benefits in this group of older adults.
Why fish oil supplements may work differently from fish and whole foods
The findings raised an important question for researchers: If omega-3s reach the brain, why do higher levels not necessarily improve brain function?
Yassin and his colleagues are studying how the brain absorbs, processes, and uses these nutrients. Their early research suggests that omega-3s may be more beneficial as part of a broader dietary pattern rather than when taken alone as a supplement.
One possibility is a Mediterranean-style diet that emphasizes fish, vegetables, fruits, whole grains, legumes, nuts, and olive oil. This dietary pattern provides omega-3 fatty acids along with other nutrients and is associated with a lower risk of Alzheimer’s disease.
Researchers believe that the combination of nutrients in a balanced diet, along with a person’s overall health, may influence how effectively omega-3s support the brain.
“We are focused on better understanding how the brain processes omega-3s and whether factors such as poor health, dietary patterns, genetic risk, and age can alter the brain’s ability to effectively absorb and utilize omega-3s,” Yassin said. “We are working to develop drugs that may help the brain better utilize these nutrients to maintain cognitive function.”
Understanding these differences may help scientists determine why some people respond better to omega-3s than others and how future treatments could improve the brain’s ability to use these essential fats.
Importantly, the study does not show that omega-3 fatty acids are unnecessary or that eating fish lacks health benefits. Instead, it found that taking high-dose DHA supplements alone did not provide measurable protection against cognitive decline or hippocampal shrinkage in the population studied.
Healthy habits remain important for Alzheimer’s disease prevention
Although the trial focused specifically on fish oil supplements, researchers emphasized that protecting brain health requires a broader approach.
Rather than relying on a single supplement, they recommend maintaining healthy habits throughout life, including regular physical activity, sufficient quality sleep, and a nutritious, balanced diet.
These habits may support overall health and help reduce factors associated with cognitive decline. Exercise promotes cardiovascular health and blood flow, while sleep plays an important role in memory formation and maintaining a healthy brain.
“Maintaining good health throughout life remains the most powerful tool for reducing Alzheimer’s disease risk, including regular exercise, quality sleep, and a balanced diet,” Yassin said. “Living a healthy lifestyle is the brain equivalent of regular car maintenance and a high-quality oil change. Just as a car’s engine stalls if you skip regular maintenance, your brain is more likely to lose function if health problems in other parts of your body go unchecked.”
Although these lifestyle factors have not been directly tested in trials, researchers believe they provide a more promising foundation for long-term brain health than relying on fish oil supplements alone.
The findings also highlight an important distinction: A nutrient can be essential for healthy brain function without providing additional protection when taken in large amounts as a supplement. Understanding why this happens could open new avenues for research into Alzheimer’s disease prevention and the nutritional needs of the aging brain.
This research was supported by the National Institutes of Health, including grants RF1AG076124, R01AG055770, R01AG067063, R01AG054434, R21AG056518, and P30AG066530, as well as the Alzheimer’s Disease Drug Discovery Foundation grant GC-201711-2014197.
Source: www.sciencedaily.com


